When accessing the CDB site through an internal Novo Nordisk IP address, you will see "Your Location" as NN Internal instead of a country. This only applies to internal NN IP addresses. Thank you for your patience while the development team is upgrading this feature.

Your Location: USA

Help Join the Cause Submit Data

Bookmark and Share
Diabetes Data Collection

How Data is Collected

Data for the Changing Diabetes Barometer is collected in various ways and comes our way from various resources, with the bulk of information coming from published studies and diabetes registries.

Novo Nordisk representatives worldwide are responsible for the collection of local data related to key diabetes indicators. As of 2008, more than 70 countries had participated in submitting data for to the Changing Diabetes Barometer.

Internationally recognised sources have also been instrumental in the collection of diabetes data. In particular the International Diabetes Federation (IDF) has been very cooperative in sharing data, especially related to diabetes prevalence and complications. Data published on this site which differs from that found either on the Diabetes Atlas or IDF can be attributed to either updates made to either source or due to recommendations and new resources for data from local diabetes experts.

Internal Review of Data

Although Novo Nordisk takes full responsibility for the data available on this site and in particular, the Diabetes Data section, apart from expert review to ensure quality of data submitted, this website exercises no further editorial control over the data which appears.

All data submitted directly to the Changing Diabetes Barometer website is reviewed by a panel of experts before it is published on the site. This data is also shared with the IDF Diabetes Atlas team. If you have published collected diabetes data in a clinical/hospital setting, please help to further the Changing Diabetes Barometer initiative by Joining the Cause and Submitting Data.

For National Plans, information is drawn from a global survey conducted by the IDF with support from Novo Nordisk.

Studying and Using the Data

Collecting diabetes data is more than an academic exercise. In order for the collected data to be meaningful, it must be studied and used so that we can learn from existing actions and encourage constructive competition to build a better approach to diabetes care policy, as well as clinical and personal decision making.

Because information around the world is collected using varying methods and standards, site users should take care when comparing data between countries and drawing conclusions. Making comparisons can be a useful source of inspiration, and raises important questions about differences in outcomes, but direct conclusions are only valid if the circumstances and populations are similar.

Healthcare providers are encouraged to interpret the data, benchmark their results against their peers, and identify areas for improvement. While performance can be compared with recommended target values, many healthcare providers may feel that greater meaning is found by comparison with data from peers in other clinics, regions, and countries.

Return To Top

Progress is Possible

See how diabetes trends can be reversed

Learn How

Global Diabetes Events

Upcoming events in the global diabetes community

Mark Your Calendar

Join the Cause

Answer the call to measure, share, and improve

Join the Cause